BIOMAT Database Logo BIOMAT Database Logo

Spironolactone and hydrochlorothiazide in normal-renin and low-renin essential hypertension. 1977

R K Ferguson, and D M Turek, and D R Rovner

The relative blood pressure response and side effects of spironolactone (S), 400 mg/day, and hydrochlorothiazide (H), 100 mg/day, were evaluated in a double-masked crossed comparison. Subjects were 24 essential hypertensives, 13 normal and 11 with low renin activity. Upright renin levels were determined in the AM after 3 days of moderately low sodium diet (less than 100 mEq/day) and at the end of each drug treatment period. The values were not revealed to one investigator until completion of the study. After 4-week placebo control periods, either S or H was given in divided doses for 6 weeks. Blood pressure measurements and side effects were evaluated at biweekly intervals. The fall in blood pressure from control was the same for each drug and was independent of renin activity. Side effects occurred more often in patients treated with S, and H was judged superior by risk/benefit analysis. We conclude that S is no more beneficial than H in hypertensive patients with either low or normal renin activity but induces a higher incidence of adverse effects in the dose used in this study. We found no evidence for a greater effectiveness of S in low-renin essential hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006852 Hydrochlorothiazide A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. Dichlothiazide,Dihydrochlorothiazide,Esidrex,Esidrix,HCTZ,HydroDIURIL,Hypothiazide,Oretic,Sectrazide

Related Publications

R K Ferguson, and D M Turek, and D R Rovner
Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
February 1974, JAMA,
R K Ferguson, and D M Turek, and D R Rovner
Spironolactone and hydrochlorothiazide in essential hypertension. Blood pressure response and plasma renin activity.
December 1972, Archives of internal medicine,
R K Ferguson, and D M Turek, and D R Rovner
Similar effects of hydrochlorothiazide and spironolactone on plasma renin activity in essential hypertension.
January 1972, Cleveland Clinic quarterly,
R K Ferguson, and D M Turek, and D R Rovner
Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
January 1983, Canadian Medical Association journal,
R K Ferguson, and D M Turek, and D R Rovner
Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone.
September 1973, The American journal of cardiology,
R K Ferguson, and D M Turek, and D R Rovner
Diuretic therapies in low renin and normal renin essential hypertension.
July 1977, Clinical pharmacology and therapeutics,
R K Ferguson, and D M Turek, and D R Rovner
Letter: Adrenergic reactivity in low renin and normal renin essential hypertension.
August 1976, Circulation research,
R K Ferguson, and D M Turek, and D R Rovner
[High-dose spironolactone therapy in essential hypertension patients with low plasma renin].
January 1973, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
R K Ferguson, and D M Turek, and D R Rovner
Hydrochlorothiazide and spironolactone in hypertension.
January 1979, Clinical pharmacology and therapeutics,
R K Ferguson, and D M Turek, and D R Rovner
The effect of spironolactone (Aldactone) and methyldopa in low and normal renin hypertension.
June 1975, Acta medica Scandinavica,
Copied contents to your clipboard!